Keyvantage Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Buy
4,379
+407
+10% +$94.8K 0.47% 36
2025
Q4
$822K Buy
3,972
+462
+13% +$91.4K 0.35% 41
2025
Q3
$651K Sell
3,510
-50
-1% -$8.57K 0.27% 50
2025
Q2
$544K Sell
3,560
-594
-14% -$91.3K 0.24% 56
2025
Q1
$689K Buy
4,154
+721
+21% +$113K 0.34% 43
2024
Q4
$496K Buy
+3,433
New +$532K 0.36% 52

Other funds holding JNJ

Keyvantage Wealth's JNJ Position: Q1 2026 in Review

Keyvantage Wealth increased its Johnson & Johnson (JNJ) stake by 10% in Q1 2026, buying an estimated $94.8K and bringing the position to 4,379 shares worth $1.07M. The position accounts for 0.47% of the portfolio, ranked #36.

Keyvantage Wealth first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Keyvantage Wealth held 4,379 shares of Johnson & Johnson worth $1.07M as of Q1 2026.
  • Keyvantage Wealth bought 407 Johnson & Johnson shares in Q1 2026, an estimated $94.8K.
  • Johnson & Johnson made up 0.47% of Keyvantage Wealth's portfolio in Q1 2026, its #36 holding.
  • Keyvantage Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Keyvantage Wealth's 13F filing for Q1 2026, filed 5 May 2026.